[Results of cobalt-60-irradiation of brain tumors].
The periods of survival which can be obtained on patients with a primary tumor of the brain after an unique or post-operative cobalt-60-irradiation is dependent of the histology: while periods of survival of several years have been obtained in case of medulloblastoma and astrocytoma, the irradiation of the multiform glioblastoma represents only a palliative measure with a temporary amelioration for any months.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001254:Astrocytoma / Q000532:radiotherapy; D001932:Brain Neoplasms / Q000532:radiotherapy*; D002648:Child; D002675:Child, Preschool; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003397:Craniopharyngioma / Q000532:radiotherapy; D005260:Female; D005909:Glioblastoma / Q000532:radiotherapy; D006801:Humans; D007223:Infant; D008297:Male; D008527:Medulloblastoma / Q000532:radiotherapy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010166:Palliative Care; D011867:Radioisotope Teletherapy / Q000009:adverse effects; D012737:Sex Factors; D013997:Time Factors
D003037:Cobalt Radioisotopes
Ergebnisse der Kobalt-60-Bestrahlung von Hirntumoren